The present study was designed to determine the influnot significantly increase collagenase levels. Western blot and ELISA data showed that VEGF treatment sigences of vascular endothelial growth factor (VEGF) on cell proliferation and the release of matrix metallopronificantly decreased TIMP-1 and TIMP-2 levels compared to untreated cultures. The data suggest that VEGF teinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) from human dermal microvascular endomay modulate endothelial cell-derived MMP activity by:
INTRODUCTION
treatment. An ELISA assay confirmed that VEGF treatment significantly increased gelatinase A levels but did Angiogenesis, also referred to as neovascularization, is the formation of new blood vessels from preexisting Undesirable angiogenesis also manifests as a pathologimembrane and surrounding ECM must occur. This degradation of the ECM serves to release the endothecal response in arthritis (Peacock et al., 1992) , duodenal ulcers (Szabo, 1974) , and tumor growth (Folkman, 1995) lial cells from their basement membrane and to provide a route by which to migrate. Clearance of the basement and during ocular neovascularization such as in diabetic retinopathy (Davis, 1994; Frank, 1984) . Initiation membrane prior to release and migration requires the production of extracellular matrix-degrading proteinof pathological angiogenesis requires at least four events: (1) a hypoxic episode that stimulates the release ases. One family of such enzymes is the matrix metalloproteinases (MMPs). The MMPs are zinc proteases that of mitogens; (2) mitogenic activation of vascular endothelial cells to induce their proliferation; (3) migration cleave components of the ECM. There are three major types of MMPs: the collagenases, the stromelysins, and of endothelial cells toward the source of a chemotactic stimulus; and (4) degradation of the extracellular matrix the gelatinases (Matrisian, 1992) . The collagenases (interstitial collagenase or MMP-1, neutrophil collagenase (ECM) surrounding the vessel to permit endothelial cell invasion into new territories (Ferrara, 1995; Klagsbrun or MMP-8 , and collagenase-3 or MMP-13) degrade fibrillar collagens and proteoglycans. There are two gelaand D'Amore, 1991). As endothelial cells proliferate and migrate, they form endothelial cell sprouts or cords tinases, termed gelatinase A and B (MMP-2 and -9, respectively), which degrade basement membrane-type and eventually form a new capillary network (Pardenaud et al., 1989) . Thus, new vessel formation requires collagen (IV) as well as types V, VII, and X collagens. The stromelysins, which include stromelysin-1 (MMPa complex series of events for vascular endothelial cells to proliferate in their traditional location and migrate 3), stromelysin-2 (MMP-10), stromelysin-3 (MMP-11), and matrilysin (MMP-7), degrade proteoglycans, collainto sites distant from this location.
In pathologies that display angiogenesis, the initial gens X and XI, fibronectin, and laminin. In addition to the common feature that these enzymes degrade at least event that appears to stimulate new vessel growth is hypoxia (Folkman, 1995) . Hypoxia is a potent stimulaone component of the extracellular matrix, all are secreted as partially active zymogens that require proteotor of angiogenesis, inducing the expression of vascular endothelial growth factor (VEGF) (Brogi et al., 1994) . lytic cleavage for maximum activation (Nagase et al., 1992a) . This proteolytic loss of amino acids is readily Induction of VEGF production by hypoxia has been observed in tumor angiogenesis (Hlatky et al., 1994; Sa- apparent during electrophoretic separation of the enzymes during substrate gel electrophoresis, or zymogmoto et Shweiki et al., 1995; Warren et al., 1995; Weindel et al., 1994) and in ocular angiogenesis raphy. For example, gelatinase A is secreted as a latent 72-kDa proenzyme that upon proteolytic cleavage shifts (Adamis et al., 1994; Aiello et al., 1994; Frank et al., 1994; Hata et al., 1995; Miller et al., 1994) . VEGF is therefore migration on gelatin zymograms to a 66-kDa partially active proenzyme and a 62-kDa fully active enzyme important in the hypoxic initiation of endothelial cell proliferation and migration that are required for angio- (Overall et al., 1989) . All MMPs exhibit this electrophoretic mobility shift when activated by proteolysis (Nagenesis to occur (Folkman, 1995) . Numerous other exogenous signals regulate angiogenesis in vivo. Such gase et al., 1992b) . Increased expression of MMPs has been observed in the vitreous of proliferative diabetic other enhancers of angiogenesis include basic fibroblast growth factor (FGF-2), epidermal growth factor, and retinopathy patients that exhibit angiogenesis, suggesting a role for MMPs in this ocular pathology platelet-derived growth factor. Of these various factors, FGF-2 and VEGF are synergistic endothelial cell mito- Sanchez et al., 1991) . Control of MMP activity in vivo is regulated, in part, gens (Goto et al., 1993; Pepper et al., 1992) . The coordinated expression of these mitogens may be induced by by tissue inhibitors of metalloproteinases (TIMPs). There are three known TIMPs (TIMP-1, -2, and -3) that bind to release of cytokines and other factors by cells in the hypoxic tissue (Brogi et al., 1994) . latent MMPs to inhibit ECM proteolysis. TIMPs interact with their appropriate proenzyme at the protease's amino To accommodate the migration of the proliferating cells, a finely regulated degradation of the basement terminus, the region flanking the enzyme's active site.
The resulting stearic hindrance effectively blocks the al., 1992) . During the induction of cell proliferation and Diego, CA) and maintained at 37ЊC, 5% CO 2 in endothemigration, there must be either a shift in the relative prolial cell basal media containing 10 ng/ml epidermal tein levels of MMPs and TIMPs or a dissociation of TIMPs growth factor, 1 mg/ml hydrocortisone, 50 mg/ml genfrom the MMP. Once free of the inhibitor, the enzyme tamicin, 50 ng/ml amphotericin B, 0.4% bovine brain undergoes a two-step activation process that first involves extract, and 5% fetal bovine serum (Clonetics). Cells a conformational change in the enzyme followed by prowere used during early passage (4 -6) and placed on teolytic cleavage of approximately 10 kDa from the amino uncoated culture plates. terminus. The proteolytic cleavage results in an increase in MMP activities (Denhardt et al., 1993) .
MATERIALS AND METHODS
An apparent correlation between the activity of
Endothelial Cell Proliferation and MMP Release
MMPs and angiogenesis has been described. For example, inhibitors of MMP activity decrease angiogenesis To determine the optimal dose of VEGF that would generate proliferation, HMVECd cells were plated onto in tumors in vitro (Fan et al., 1995; Moses and Langer, 1991) , and TIMP-3 inhibits the chemotaxis of human plastic cell culture plates at a density of Ç1250 cells per well, incubated at 37ЊC and 5% CO 2 , and allowed to umbilical vein endothelial cells toward either of the mitogens VEGF or FGF-2 in vitro (Anand-Apte et al., attach to the substrate for 24 h. At the end of the 24-h period, the cell density (number of cells/mm 2 ) was 1997). Similarly, microvascular endothelial cells from bovine retina did not form vessel cords in vitro in the calculated using an ocular grid and inverted microscope (Nikon TMS). Cells were then treated with VEGF presence of TIMP-3 (Anand-Apte et al., 1997) . Further evidence for an MMP role in pathological angiogenesis (Collaborative Biomedical Products) concentrations ranging from 0 to 100 ng/ml and the cultures were comes from the discovery that gelatinase levels are directly correlated with the extent of neovascularization returned to 37ЊC and 5% CO 2 for an additional 24 h. At that time, total cell density was again calculated and in tumors in vivo (Liotta et al., 1991) . Together, these data suggest that regulation of MMPs is crucial for inhithe percentage increase in cell density determined. In separate subsequent experiments designed to debition or enhancement of angiogenesis.
In tumor metastasis and several retinopathies, hyptermine the effect of VEGF on MMP release, the cells were allowed to grow to approximately 80% confluoxia and subsequent VEGF production are clearly involved in the induction of angiogenesis. Since release ency, the medium was removed, and the cultures were rinsed with serum-free medium and then incubated for of endothelial cells from their basement membrane and migration through the surrounding ECM may require 24 h in serum-free medium with or without 10 ng/ml VEGF, the former of which had been found to produce the release of MMPs, we examined the role of VEGF in regulating endothelial cell proliferation as well as in maximal proliferation in the experiment described above. The use of serum-free medium during rinses regulating the levels of MMPs and TIMPs released by microvascular endothelial cells in vitro. We used a variand as a vehicle for the treatment of the cells with VEGF was designed to remove endogenous metalloproteinety of techniques (zymography, Western blots, and ELISA) to demonstrate and quantify the changes in the ases found in tissue culture serum additive. Serum-free medium incubated without cells was also used in some levels of the active and latent forms of specific MMPs and in the levels of TIMPs produced in response to experiments to confirm the absence of contaminating serum MMPs. Cell morphology was checked visually VEGF.
after the 24-h incubation to determine the relative were stained overnight in Coomassie brilliant blue R-250 and then destained twice in 50% methanol, 10% health of the culture. Cells visually appeared to have retained their normal fibroblast-like morphology in the acetic acid for 30 min each, followed by an overnight destain in 10% methanol, 7% acetic acid. Zones of clearabsence of the serum additive, with very few cells exhibiting granulation or vacuole accumulation, both ing in the gel indicated MMP activity. The apparent molecular weights of the MMPs were compared to morphological indicators of abnormal cell metabolism. The media were then analyzed using zymography for prestained standards as well as MMP standards derived from cytokine-treated macrophages. These stantotal gelatinolytic activity and Western blots to determine the presence of both metalloproteinases and dards included partially and fully activated forms of gelatinase B and gelatinase A. Gels were run in tripliTIMPs. To quantify the effect of VEGF on altering MMP levels in vitro, an enzyme-linked immunosorbent assay cate from three separate pairs of cultures. (ELISA) was performed.
Western Blot Zymography
Zymography is a sensitive assay for detecting some (such as gelatinases) but not all (e.g., collagenase) meGelatin zymography is a sensitive technique that detects activated gelatin-degrading metalloproteinases talloproteinases. To determine levels of the enzymes interstitial collagenase, gelatinase A, gelatinase B, and (gelatinase A, gelatinase B, and a truncated stromelysin-1) (Heussen and Dowdle, 1980) . For this study, culstromelysin-1, as well as levels of two of the tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2), ture media were collected by aspiration, centrifuged to remove cellular debris, and concentrated using an culture media were examined using Western blot analysis. One paired culture (one of the pair treated with 10 ultrafiltration device (Centricon 10; Amicon). Total protein concentration was determined by a modified ng/ml VEGF and the other untreated) was examined for the presence and levels of the following enzymes Lowry assay (Bio-Rad DC protein assay). Total protein concentrations were equalized and 30 mg total protein and inhibitors: interstitial collagenase, gelatinases A and B, stromelysin-1, and TIMP-1 and -2. The media per lane was analyzed by gelatin zymography. This conservative method of equalization compensated for from these cultures were analyzed by duplicate Western blots. The antigens gelatinase B and stromelysin-1 changes due to differences in cell number as a result of VEGF treatment. Zymography detects mainly metallowere not detected in the medium from either the VEGFtreated or the untreated control cultures. Consequently, proteinases that were activated in vivo; however, SDS treatment may have converted some unknown percentthe presence of these enzymes was not further analyzed in subsequent Western blot detection. Media from two age of the latent metalloproteinase to its active form (Overall et al., 1989) . We are unable to determine by more pairs of cultures (VEGF-treated and untreated controls) were analyzed either once or in duplicate by zymography any changes in the amount of latent metalloproteinase produced by VEGF treatment. Samples
Western blot for the presence and levels of interstitial collagenase, gelatinase A, TIMP-1, and TIMP-2. Interstiwere applied without prior boiling to an 8% polyacrylamide gel containing 0.1% sodium dodecyl sulfate and tial collagenase was assayed because of its reported involvement in metalloproteinase production by hucopolymerized with 1 mg/ml gelatin. Samples were electrophoresed at 100 mA, and the gels were rinsed man umbilical vein endothelial cells (Unemori et al., 1992) . Gelatinase A was chosen because it was of the three times for 1 min each in dH 2 O and finally rinsed three times for 15 min each in Triton wash buffer (25% approximate size of the band of activity shown in the zymograms. The rationale for testing for the presence Triton X-100, 50 mM Tris, pH 7.6, 10 mM CaCl 2 , and 1 mM ZnCl 2 ). After rinsing, the gels were incubated at of stromelysin-1 (nontruncated form) was that this enzyme shows little gelatinolytic activity and could have 37ЊC for 20 h in 50 mM Tris, pH 7.6, 10 mM CaCl 2 , 0.1% NaN 3 , 1% Triton X-100, and 1 mM ZnCl 2 . The gels been present in the media without being detected by gelatin zymography. We also used the Western blot pH 9.5, prepared according to the manufacturer's instructions. technique to confirm the absence of gelatinase B as indicated by zymography. Experiments in which the primary antibodies were omitted were also performed as Densitometry controls against nonspecific staining. All such primary omission experiments resulted in no immunostaining
To determine if VEGF treatment altered levels of enzyme or inhibitor released into the media, zymograms of the Western blots.
Samples were reduced with 2-mercaptoethanol and and Western blots were analyzed by densitometry using NIH Image version 1.59 and a gel analysis macro. denatured by boiling for 5 min prior to electrophoresis. Equal amounts of total protein for each sample were
Triplicates of zymography gels and five blots for each antigen were analyzed by densitometry. Images of the electrophoresed through a 10% SDS -PAGE gel at 150 V for 1 h. Some gels were stained in Coomassie brilliant gel or nitrocellulose were scanned with a flatbed scanner (Hewlett-Packard ScanJet IIc) and the image was blue for total protein to ensure that samples were approximately equivalent in staining. Following electroviewed with a Macintosh Performa computer. The optical density of the lanes containing the bands was meaphoresis, the gel, nitrocellulose, and blotting filters were equilibrated for 20 min in Towbin transfer buffer (25 sured using NIH Image 1.59 and relative changes in the integrated area under the peak represented relative mM Tris, pH 8.3, 193 mM glycine, 20% methanol) (Towbin et al., 1979) . Proteins were transferred electrophoretchanges in protein concentration. To further quantify changes in MMP and TIMP levels an ELISA assay was ically using a wet blotting apparatus (Mini TransBlot, Bio-Rad) for 60 min at 100 V and 4ЊC. Following transperformed on media from VEGF-treated and untreated cultures as detailed below. fer, the nitrocellulose was blocked in 3% gelatin in Trisbuffered saline with 0.1% Tween 20 (TBST). Following three 5-min washes in TBST, the membranes were incuEnzyme-Linked Immunosorbent Assay bated in monoclonal primary antibodies directed against human interstitial collagenase, human gelaAn enzyme-linked immunosorbent assay was performed using polyclonal antibodies to further detertinase A, human gelatinase B, human stromelysin-1, human TIMP-1, or human TIMP-2 (Oncogene Science) mine whether VEGF treatment altered the levels of specific MMPs or TIMPs in the media. The monoclonal diluted 1:1000 in TBST for 2 h at room temperature. The antibody directed against collagenase recognizes antibodies employed in the Western blots were not successful in these ELISA assays. The MMPs and TIMPs both latent (55 kDa) and active (45 kDa) forms of the enzyme, whereas the antibody directed against gelamay have bound to the plastic plate in such a way as to obscure the antigenic sites against which the monotinase A recognizes only the latent (72 kDa) form under denatured conditions. As the TIMPs do not have latent clonal antibodies were directed. The use of polyclonal primary antibodies in the ELISA assays was thus necesand active forms, only one molecular weight species for each antigen was detected (28 kDa for TIMP-1 and sary for antigen detection. Media from six VEGFtreated samples were pooled for the assays, as were the 21 kDa for TIMP-2). The denaturation that occurred in sample preparation also freed TIMP -MMP complexes, media from six untreated control cultures. Wells of a microtiter plate were coated with 10 mg/ml of medium allowing the monoclonal antibodies to detect the metalloproteinases and TIMPs separated from one another. in 0.2 M sodium carbonate -bicarbonate buffer, pH 9.4, for 1 h at room temperature. Wells were rinsed with The primary antibodies were detected using a biotinylated secondary antibody in conjunction with an avidinmodified Dulbecco's phosphate-buffered saline (DPBS; 8 mM sodium phosphate, 2 mM potassium phosphate, biotin complex/alkaline phosphatase kit (Vectastain ABC-AP; Vector Laboratories). The substrate for the 0.14 M sodium chloride, 10 mM potassium chloride, pH 7.4) containing 0.5% Tween 20 (DPBST). Nonspecific alkaline phosphatase was 5-bromo-4-chloro-3-indoyl phosphate and nitroblue tetrazolium in 100 mM Tris, binding sites were blocked with 1% BSA in DPBS for 1 h at room temperature and then rinsed in DPBST. ment of band densities in zymograms and Western blots was by use of paired one-tailed t tests. For analysis Specific antigens were detected using one of the following polyclonal primary antibodies (1:500 in 1% BSA in of the ELISA data, replicates of 10 wells for each antigen tested were used. The absorbance readings of the ELISA DPBS): antibodies to interstitial collagenase, gelatinase A, TIMP-1, or TIMP-2 (Chemicon). The polyclonal antiassays of VEGF-treated versus untreated control cultures were compared for statistical significance using a bodies recognized both the latent and the active forms of the interstitial collagenase and gelatinase A. Plates x 2 analysis. The calculated P values are reported for each enzyme or inhibitor. All statistical tests were percontaining the primary antibodies were incubated at room temperature for 1 h and then rinsed in DPBST.
formed using StatView 512 / for the Macintosh. Detection of the primary antibodies was accomplished by incubation of the antigen -primary complex with anti-rabbit IgG secondary antibodies conjugated with RESULTS alkaline phosphatase, diluted 1:5000 in 1% BSA in DPBS for 1 h at room temperature, followed by rinses in DPBST. Following the rinses, the enzyme substrate (0.5
Dose Response of Endothelial Cell Proliferation to mg/ml p-nitrophenyl phosphate in diethanolamine
Treatment with VEGF buffer, pH 10.0) was added and the enzyme -substrate reaction was allowed to proceed for 30 min. The reAll cultures exhibited a significant increase in cell sulting colorimetric reaction was read at 415 nm using density following a 24-h treatment (Table 1) , but the a microplate reader (MR700; Dynatech).
proliferation in untreated cultures and in cultures treated with 5 ng/ml VEGF was statistically indistinguishable and therefore likely due to a normal mitotic
Statistical Analysis
increase in cell number. For cultures treated with VEGF at concentrations ranging from 10 to 100 ng/ml, the To compare proliferation rates of HMVECd cells in response to treatment with VEGF, cell densities were percentage increases in cell density were statistically greater than those for the untreated cultures or cultures analyzed by a repeated-measures ANOVA method. Differences in the effect of various VEGF concentrations treated with 5 ng/ml (P õ 0.001). Among the VEGFtreated cultures, there were no statistical differences in on cell proliferation compared to untreated controls are reported. Statistical analysis of the densitometric assesscell densities between a concentration of 10 mg/ml Note. Cell density ({SE) was calculated after the cells were allowed to attach for 24 h and again 24 h following treatment with VEGF or media alone. Statistical precision is based on an ANOVA repeated-measures analysis comparing VEGF-treated cultures (5 -100 ng/ml) to untreated control cultures (0 ng/ml). n/a, not applicable.
a Statistical significance compared to 5 ng/ml, P Å 0.0001. b Statistical significance compared to 5 ng/ml, P Å 0.0042. c Statistical significance compared to 5 ng/ml, P Å 0.0008.
VEGF and concentrations greater than 10 ng/ml (Table  1) . Thus, the data suggested that 10 ng/ml VEGF yielded maximal microvascular endothelial cell proliferation and may have yielded maximum binding of VEGF to available receptors. We therefore used this concentration in all subsequent experiments on the effects of VEGF treatment on MMP and TIMP levels.
Zymography
To determine the effect of VEGF on MMP release, the HMVECd were treated with 10 ng/ml VEGF for 24 h and the media collected and assayed for total gelatinolytic activity. When the media from the endothelial cells were examined by zymography, two zones of clearing were seen in the media from VEGF-treated cells and from untreated control cells (Fig. 1 ). These gelatinolytic bands had apparent molecular weights of 66 and 62 kDa. The molecular weights of these gelatinases were identical with the estimated sizes of partially and fully activated gelatinase A, respectively (Matrisian, 1992) .
FIG. 1. Gelatin zymogram of culture media from microvascular en-
Using gel densitometry to determine relative amount dothelial cells treated with 10 ng/ml vascular endothelial growth of clearing, and thus protein levels, the gelatinolytic factor (/VEGF) and control media from the same cell type (0VEGF).
activity (combined partially active and fully active
The MMP standard lane contains a known mixture of gelatinases forms) in the media from VEGF-treated HMVECd cells derived from cytokine-stimulated macrophages, with the enzyme molecular weight (kDa) and name listed to the right. Gelatinase B p , was determined to be 19.7% greater than the control partially activated gelatinase B; gelatinase B f , fully activated gela- (Fig. 1, Table 2 ). tinase B; gelatinase A p , partially activated gelatinase A; gelatinase A f , fully activated gelatinase A.
Western Blot Analysis
The media from the control and VEGF-treated cells were examined by Western blot analysis for the presetry of the blot probed with anti-gelatinase A antibody exhibited a significant increase in the amount of latent ence of the metalloproteinases interstitial collagenase, gelatinase A, gelatinase B, and stromelysin-1. In both gelatinase in the VEGF-treated cultures compared to the untreated controls (Table 2; 26.6% increase, P Å control and VEGF-treated media there was positive immunoreactivity for collagenase, both the latent (55 kDa) 0.0149). There was no detectable stromelysin-1 or gelatinase B in the media from either the untreated control and the active (45 kDa) forms ( Fig. 2A) . There was no statistically significant change in collagenase levels reor the VEGF-treated cells. When the media from the VEGF-treated and untreated control cultures were analeased into the media from VEGF-treated cultures versus untreated control cultures (Table 2; overall 9.1% lyzed for the presence of TIMP-1 and TIMP-2, media were found to be positive for both inhibitors (Figs. 3A decrease for the latent and active forms combined, P Å 0.1994). The media from both VEGF-treated and unand 3B). Densitometric analyses of the blots demonstrated that VEGF treatment of the cultures decreased treated control cultures contained latent gelatinase A (72 kDa), with a more intense gelatinase A signal in the levels of TIMP-1 and TIMP-2 by 59.8 and 51.6%, respectively (Table 2 ; P Å 0.0029 and 0.0185). To confirm that media from the VEGF-treated cells (Fig. 2B) . Densitom- Note. For zymography and Western blot analyses, gels or blots were analyzed by densitometry and band density from VEGF-treated cultures was compared to untreated controls. For ELISA assays, percentage change in protein levels in media from VEGF-treated cultures was compared to levels in media from untreated cultures. Statistical significances reported for zymography are from a two-tailed t test; significances from Western blots are from a paired two-tailed t test; and significances from the ELISA assays are from x 2 . All statistical analyses compare VEGFtreated cultures to untreated controls. nd, not detected by this technique.
the differences in protein levels were the result of firming the observations made with zymography and Western blots. Western blot analyses of the levels of the VEGF-mediated release into the media, some gels were stained with Coomassie brilliant blue. All gels stained two TIMPs suggested that VEGF treatment had greatly reduced TIMP levels. Examination of TIMP levels in for total protein in this manner gave similar results; that is, the total protein profile was approximately equal in the media from the VEGF-treated and untreated endothelial cell cultures by ELISA confirmed that the levels total staining. The results from these stainings suggest that any changes in protein levels observed in the Westof both TIMPs were significantly decreased. TIMP-1 levels were decreased by 69.9% (Table 2 ; P Å 0.0001) ern blots were due to differences in that protein only and not the result of differential protein loading.
while TIMP-2 levels were decreased by 34.7% (Table 2 ; P Å 0.0001).
ELISA
To further quantify and confirm the effect of VEGF DISCUSSION on levels of MMPs or TIMPs, 10 mg/ml of total protein from the media from VEGF-treated or untreated controls was assayed for interstitial collagenase, gelatinase
Effect of VEGF on Endothelial Cell Proliferation
A, TIMP-1, or TIMP-2 levels. Examination of concentrations of total interstitial collagenase in VEGF-treated Angiogenesis as part of a pathological response can have detrimental effects, promoting such processes as and untreated control media by the ELISA technique confirmed the Western blot observation that VEGF tumor growth, arthritis, and retinal neovascularization, the last of which can lead to blindness. The process of treatment of the endothelial cells did not statistically alter collagenase levels (Table 2; 4.0% increase; P Å angiogenesis is complex and requires several steps to both initiate and terminate new vessel growth. Tumor 0.1213). Gelatinase A levels from VEGF-treated cultures were significantly increased (Table 2; 57.8%; P Å 0.0001) metastasis involves a series of events that includes angiogenesis as a late event that will both promote tumor over levels in the media from untreated controls, con-and age-related macular degeneration (Davis, 1994; Elman and Fine, 1994; Palmer et al., 1994) . In both tumor and retinal angiogenic responses, the onset of new vessel formation is correlated with an increased release of several mitogenic growth factors. The diverse mitogens that initiate the angiogenic response either directly regulate endothelial cell activities or stimulate nonendothelial cells within the vicinity of the target endothelium to produce factors that regulate angiogenesis (Cockerill et al., 1995; Klagsbrun and D'Amore, 1991; Leek et al., 1994; Zagzag, 1995) . Of these growth factors, VEGF and FGF-2 appear to specifically activate the endothelium to promote proliferation. We report here that VEGF appears to elicit a mitogenic response in microvascular endothelial cells at doses beginning at 10 ng/ml, which also appears to promote maximal proliferation. This dose falls within the range of concentrations of VEGF needed to stimulate proliferation of large vessel-derived (macrovascular) umbilical vein endothelial cells, which has been reported to be from õ0.1 to 50 ng/ml buffer. Previous reports have demonstrated that latent progelatinases can be activated in vitro to both partially (Unemori et al., 1992) . Our data suggest that although treatment with 5 ng/ml VEGF may have elicited a proactive and fully active forms by SDS (Overall et al., 1989) . liferative response, that response was not demonstrably greater than typical mitotic activity with the sample The observed increase in gelatinase A levels was quantified by densitometric analyses of both zymosize examined. Addition of VEGF beyond the 10 ng/ ml dosage did not appear to significantly further ingrams and blots as well as by an ELISA. Because the polyclonal antibody employed in the ELISA recognized crease the mitogenic response, presumably due to maximal VEGF receptor occupancy.
both the latent and the active forms of the enzyme, the increase observed with the ELISA is likely to be a more complete representation of the relation between VEGF
Effect of VEGF on MMP Release
treatment and gelatinase A release into the media. Conby Endothelial Cells sistent with this notion, combining the increase in activated gelatinase A seen with zymography (19.7%) and Collagenase was present in the media from both the control and the VEGF-treated cultures with no signifithe increase in the latent gelatinase A seen with Western blots (26.6%) approximately yields the increase obcant increase in the amount of collagenase released into the media due to the VEGF treatment. The dose of served by the ELISA (57.8%). Thus, neither zymography alone nor Western blots alone may have given a VEGF used in our study (10 ng/ml) was similar to the concentration used in stimulating macrovascular vein full estimate of the gelatinase A increase produced by VEGF. Since the antibody employed in the ELISA techendothelial cells to produce collagenase (Unemori et al., 1992) . Interstitial collagenase was not detected in our nique recognized both latent and active forms of gelatinase A, we believe that data from this technique best zymograms due to its poor affinity for the gelatin substrate. If the interstitial collagenase released by microrepresent the actual increase in gelatinase A released into the media. A recent report by Jackson and colvascular endothelial cells is at basal levels, then increased proteolysis of the ECM by interstitial collagenleagues also confirms that gelatinase A activity is increased in several types of endothelial cells treated with ase must be accomplished by removing TIMP-1 bound to the latent form of this enzyme. We did find that VEGF or exposed to hypoxia (Jackson et al., 1997) . It is therefore likely that an increase in gelatinase A activity treatment of endothelial cells with VEGF decreases the amount of TIMP-1 found in the media, thus in principle is necessary for endothelial cell release from the basement membrane as well as for invasion into new territoallowing interstitial collagenase to assume a form capable of proteolysis. Zymography and Western blot analyries during angiogenesis. ses failed to detect any stromelysin-1 or gelatinase B in either the VEGF-treated or the untreated control media,
Effect of VEGF on TIMP Release
and as such they were not analyzed by the ELISA assay.
by Endothelial Cells
Differences in molecular weight estimates from the gelatinase A bands in the zymogram versus the West-
The in vivo regulation of matrix metalloproteinase activity is modulated by the naturally occurring tissue ern blot were observed. These differences are due to the proteolytic processing required for activation of the inhibitors of metalloproteinases or TIMPs. There are at least three types of TIMPs, designated TIMP-1, TIMPenzyme. The Western blot assay demonstrated the presence and relative abundance of the latent (72 kDa) pro-2, and TIMP-3. TIMPs bind at the amino terminus of metalloproteinases and block the active sites, thereby enzyme form. The gelatin zymograms, conversely, represent the partially activated enzyme (66 kDa) and the denying the enzyme access to substrates (Denhardt et al., 1993) . Decreasing TIMP levels leads to an increase in fully active form which have undergone proteolysis (62 kDa). Some of the activation of the gelatinase A may proteolysis of the ECM, thus promoting macrovascular endothelial cell migration (Johnson et al., 1994 ; Khokha, have been due to the presence of SDS in the sample 1994). In this report, treatment of microvascular endorelease by the ECM components ensures that only the proteases appropriate for the prevailing substrate are thelial cells with VEGF decreased the levels of TIMP-1 and TIMP-2 released into the media compared to conreleased into the environment. Since endothelial cells that are participating in angiogenesis must both release trol cells. Coupled with the increase in gelatinase A levels in the same media, this suggests that VEGF may from their basement membrane and migrate through the neighboring ECM, and since MMPs participate in lower the levels of TIMP-2 and increase the levels of the TIMP-2 substrate, gelatinase A, shifting the balance this ECM dissolution and subsequent cell release and migration, it is of importance to determine the possible of inhibitor:enzyme toward a stoichiometry that favors ECM degradation and presumably cell migration. Furcontributions of MMPs to angiogenesis. Further, it is also necessary to consider the source of the endothelial ther, lowering levels of TIMP-1 by VEGF treatment appears to favor increasing the activity of collagenase and, cell in determining the interactions of ECM, endothelial cell type, and MMPs produced during angiogenesis. therefore, would increase the degradation of collagenase-specific substrates.
Macrovascular endothelial cells from umbilical vein grown on uncoated cultureware produce interstitial collagenase when treated with 100 ng/ml VEGF (UnRole of Endothelial Cell Type in Regulating ECM, emori et al., 1992) . When umbilical vein endothelial cells
MMPs, and TIMPs during Angiogenesis
treated with VEGF were assayed for gelatinase A, there was no detectable gelatinase A released into the media, In a homeostatic state, endothelial cells must operate in such a way as to maintain a stable, nonmigratory although the gelatinase A mRNA was expressed (Unemori et al., 1992) . Likewise, human vein-derived endoexistence. Part of this stable existence relies on the synthesis of specific ECM components during normal cell thelial cells grown on fibronectin constitutively express interstitial collagenase, yet these cells also express turnover or repair. The synthesis and release of these components organize the cell's surrounding microenviabundant levels of gelatinase A (Hanemaaijer et al., 1993) . Stimulation of vein macrovascular endothelial ronment and stabilize the endothelial cell population. There are quantifiable differences in the types of ECM cells by phorbol ester, tumor necrosis factor-a, or interleukin-1a enhanced the expression of interstitial colcomponents secreted between large vessel-derived (macrovascular) and small vessel-derived (microvasculagenase, stromelysin-1, and gelatinase B (Hanemaaijer et al., 1993) . It is therefore evident that the microenvilar) endothelial cells (Iruela-Arispe et al., 1991) . The major ECM component that is secreted by macrovascular ronment on which endothelial cells are grown may influence the production of the different MMPs. The presendothelial cells derived from bovine aorta is type III (interstitial) collagen, while endothelial cells derived ence of fibronectin on the surface of the cultureware may have influenced the macrovascular endothelial from umbilical vein synthesize type IV (basement membrane) collagen (Iruela-Arispe et al., 1991) . Microvascucells to produce stromelysin to degrade the fibronectin and influenced gelatinase A to degrade the type IV collar endothelial cells have been observed to secrete type I and type IV collagens during the organization of endolagen, whereas macrovascular endothelial cells grown on uncoated surfaces would require release of interstithelial cords in vitro (Iruela-Arispe et al., 1991) . If the microenvironment for the endothelial cells from differtial collagenase to degrade type III collagen, an ECM component that has been observed to be produced by ent origins is unique for that particular cell type, it seems likely that endothelial cells from different macrovascular endothelial cells in vitro (Iruela-Arispe et al., 1991) . Differences in MMP expression have also sources may also produce different enzymes to manipulate their microenvironment when stimulated to probeen observed for microvascular endothelial cells. Human foreskin microvascular endothelial cells grown on liferate and migrate. In fact, the components of the ECM do participate in the regulation of MMP release through fibronectin express interstitial collagenase, gelatinase A, gelatinase B, and stromelysin-1 (Hanemaaijer et al., the endothelial cell's interactions with the ECM through integrins (Werb et al., 1990) . This regulation of MMP 1993). Similar to the macrovascular endothelial cells grown on fibronectin, these microvascular endothelial activities of two MMPs: gelatinase A and collagenase. Following a hypoxic episode, VEGF is released from cells are likely producing these enzymes to degrade collagen type III (interstitial collagenase), type IV (gelaone to several cell sources, depending on the tissue and pathology involved. An increase in the levels of VEGF tinases A and B), and fibronectin (fibronectin). Microvascular endothelial cells derived from rabbit brain would lead to increased mitogenic stimulation of endothelial cell proliferation. Subsequent to this VEGF stimgrown on types I and III collagen secrete both interstitial collagenase and stromelysin-1, but neither of the ulation of endothelial cells would be the increase in gelatinase A release, as we have shown. Concurrent gelatinases (Herron et al., 1986) . The secretion of these enzymes also is likely due to the interaction of the ECM with the increase in gelatinase A release, we observed a decrease in the levels of both TIMP-1 and -2. By dewith the endothelial cell as these MMPs are best suited to degrade collagens I and III (Matrisian 1992) . Our creasing levels of TIMP-1, preexisting collagenase would be activated and could begin ECM dissolution. data indicate that microvascular endothelial cells derived from dermis grown on uncoated cultureware ex-VEGF upregulation of gelatinase A activity coupled with increases in collagenase activity would then allow press basal levels of interstitial collagenase and gelatinase A and that the level of gelatinase A can be clearance of the ECM surrounding the endothelium to proceed. This increase in MMP activity would presumincreased with VEGF treatment. Our data also demonstrate that microvascular endothelial cells stimulated in ably allow the endothelial cells to obtain a path by which to migrate, eventually forming a capillary sprout, vitro with VEGF decrease the release of TIMP-1 and -2, thereby increasing the proteolytic activities of both vessel cord, and finally a capillary network. At this time, the temporal sequence in which enzyme activagelatinase A and preexisting interstitial collagenase. By disinhibiting both MMPs, degradation of the ECM is tion and inhibitor inactivation occur following VEGF treatment of microvascular endothelial cells is not enhanced. An increase in MMP proteolysis would make it possible for the endothelial cell to release from the known. Because of the devastating effects of neovascularization during pathological responses, the control of basement membrane following stimulation by VEGF. As VEGF levels continue to be prevalent during a hyp-MMP activity offers a means of reducing or retarding the angiogenic response and could therefore be a target oxic episode, more endothelial cells are stimulated, releasing more MMPs and allowing migration through of pharmacological inhibition of angiogenesis. the surrounding tissue to be possible. The conditions that we describe may apply only to release of the endo-
